BMS-599626 in Treating Patients With Metastatic Solid Tumors

NCT00093730 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: BMS-59926

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]